天目药业：不存在逾期担保的情形

Core Viewpoint - Tianmu Pharmaceutical (600671) announced that it plans to provide guarantees for its subsidiaries, with a total amount not exceeding RMB 35 million for the year 2025 [1] Summary by Categories Company Guarantees - The total amount of guarantees provided by the company for its subsidiaries is expected to be up to RMB 35 million for the year 2025 [1] - As of the date of the announcement, the actual external guarantee balance provided by the company and its consolidated subsidiaries is RMB 17.52504 million, which includes the newly added guarantees [1] Financial Impact - The total guarantees represent 334.55% of the company's most recent audited net assets attributable to the parent company's shareholders [1] - The company has not provided any guarantees to its controlling shareholders, actual controllers, or their related parties, amounting to RMB 0 [1] Other Relevant Information - The company has no other external guarantees and there are no overdue guarantees [1]